Swapnil Patel
Research Subjects
Swapnil Patel has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Avanish Saklani
Division of Colo‐Rectal and Peritoneal Surface Oncology, Department of Surgical Oncology Tata Memorial Hospital, Homi Bhabha National Institute Mumbai India
10 shared publications - Mufaddal Kazi
Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, India
10 shared publications - Mahesh Goel
Department of Surgical Oncology Tata Memorial Hospital and Homi Bhabha National Institution Mumbai India
9 shared publications - Shraddha Patkar
Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, India
9 shared publications Amar Prem
Department of Surgical Oncology, MPMMCC & Homi Bhabha Cancer Hospital, India
7 shared publications- Vivek Sukumar
Division of Colorectal Oncology Department of Surgical Oncology Tata Memorial Hospital Mumbai India
7 shared publications
Latest Publications
- 17 September 2026
- Published by Wiley in Colorectal Disease
- Vol. 28 (9)
Application of total mesorectal excision and lateral pelvic lymph node dissection principles in nerve‐preserving sacrectomy for sacral chordoma—A video vignette
- 17 September 2026
- Published by Wiley in Colorectal Disease
- Vol. 28 (9)
Application of total mesorectal excision and lateral pelvic lymph node dissection principles in nerve‐preserving sacrectomy for sacral chordoma—A video vignette
- 1 September 2025
- Published by Wiley in Journal of Surgical Oncology
- Vol. 132 (6) , 1097-1105
Lymph Node Mapping in Gallbladder Cancers: Analysis to Assess the Impact of Location and Number of Lymph Nodal Stations
Background and Objectives: The current staging for gallbladder cancer (GBC) considers only the number of metastatic lymph nodes without addressing their location. This study evaluates the prognostic impact of lymph node mapping (both number and location) in node positive GBC. Methods: Prospectively maintained operative database of operated GBC patients from April 2010 to March 2022 with positive lymph nodes was analyzed. Nodal burden was assessed by the number and meticulous mapping of the involved nodal stations. Outcomes were evaluated using Cox regression analysis. A new nodal staging system was formulated and compared with the current American Joint Committee for Cancer Care (AJCC) staging. Results: 222 node positive patients were included. Multivariate analysis showed that multi‐station involvement was significantly associated with poor disease‐free survival (DFS) (Hazard ratio [HR]: 0.522 [95% CI: 0.354–0.770]; p = 0.001). The 5‐year DFS of 42.9%, 35.5%, 17% and 13% ( p = 0.023) respectively was observed for positive cystic node (N1a), single positive non‐cystic node (N1b), 2 and 3 positive nodes (N2a and N2b) with multi‐station involvement. The Concordance index for the new staging system was 0.588 reflecting a 6.9% absolute improvement in the prediction capability. Conclusions: Station‐based nodal assessment predicted for survival in our node positive cohort. Pathological assessment of involved stations, in addition to the number of involved nodes, could potentially provide superior prognostic information. However, this needs to be evaluated prospectively in larger cohorts.
- 1 September 2025
- Published by Wiley in Journal of Surgical Oncology
- Vol. 132 (6) , 1097-1105
Lymph Node Mapping in Gallbladder Cancers: Analysis to Assess the Impact of Location and Number of Lymph Nodal Stations
Background and Objectives: The current staging for gallbladder cancer (GBC) considers only the number of metastatic lymph nodes without addressing their location. This study evaluates the prognostic impact of lymph node mapping (both number and location) in node positive GBC. Methods: Prospectively maintained operative database of operated GBC patients from April 2010 to March 2022 with positive lymph nodes was analyzed. Nodal burden was assessed by the number and meticulous mapping of the involved nodal stations. Outcomes were evaluated using Cox regression analysis. A new nodal staging system was formulated and compared with the current American Joint Committee for Cancer Care (AJCC) staging. Results: 222 node positive patients were included. Multivariate analysis showed that multi‐station involvement was significantly associated with poor disease‐free survival (DFS) (Hazard ratio [HR]: 0.522 [95% CI: 0.354–0.770]; p = 0.001). The 5‐year DFS of 42.9%, 35.5%, 17% and 13% ( p = 0.023) respectively was observed for positive cystic node (N1a), single positive non‐cystic node (N1b), 2 and 3 positive nodes (N2a and N2b) with multi‐station involvement. The Concordance index for the new staging system was 0.588 reflecting a 6.9% absolute improvement in the prediction capability. Conclusions: Station‐based nodal assessment predicted for survival in our node positive cohort. Pathological assessment of involved stations, in addition to the number of involved nodes, could potentially provide superior prognostic information. However, this needs to be evaluated prospectively in larger cohorts.
- 1 December 2024
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 10 (10) , e2400306
INDEPSO-ISPSM Consensus on Peritoneal Malignancies: Management of Colorectal Peritoneal Metastases
PURPOSE: This manuscript reports the results of the Indian Network for Development of Peritoneal Surface Oncology and Indian Society of Peritoneal Surface Malignancies (INDEPSO-ISPSM) consensus that aimed to provide recommendations for some important aspects management of patients with colorectal peritoneal metastases (CPM) and address some issues unique to India. METHODS: The modified Delphi technique was used with two rounds of voting. There were 29 questions on nine main topics—the role of cytoreductive surgery (CRS), patient selection for CRS, preoperative workup, role of systemic chemotherapy (SC), CPM with other visceral metastases, molecular profile, hyperthermic intraperitoneal chemotherapy (HIPEC) and other modalities of intraperitoneal chemotherapy (IPC), prophylactic/preventive strategies, and surveillances after CRS. A consensus was achieved if anyone option received >70 votes (strong consensus >90%). RESULTS: Forty-eight surgical (n = 41) and gastrointestinal (n = 7) oncologists were invited; 44 agreed to participate. The response rate was 95.4% (42/44) in round 1 and 93.1% (41/44) in round 2. Overall, a consensus was achieved on 23/29 (79.3%) questions (strong consensus on 6/29 [20.6%]). The panel strongly recommended considering surgery for limited CPM with limited liver metastases (92.5%), not altering the surgical approach in patients with KRAS mutations (91.67%), and limiting the use of IPC for unresectable CPM outside clinical trials (95%). Adjuvant SC was recommended for all patients undergoing CRS (89.47%). CRS is a therapeutic option for selected patients with CPM including those with metachronous CPM (79.49) and signet ring cell cancers (76.92%). HIPEC was recommended outside clinical trials only for patients with peritoneal cancer index 11-15(80%). CONCLUSION: The panel recommended CRS for most indications but was very selective in recommending HIPEC and IPC outside clinical trials. These recommendations should be a useful resource in clinical decision making for clinicians treating CPM in India and regions with a similar sociodemographic background.
- 1 December 2024
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 10 (10) , e2400306
INDEPSO-ISPSM Consensus on Peritoneal Malignancies: Management of Colorectal Peritoneal Metastases
PURPOSE: This manuscript reports the results of the Indian Network for Development of Peritoneal Surface Oncology and Indian Society of Peritoneal Surface Malignancies (INDEPSO-ISPSM) consensus that aimed to provide recommendations for some important aspects management of patients with colorectal peritoneal metastases (CPM) and address some issues unique to India. METHODS: The modified Delphi technique was used with two rounds of voting. There were 29 questions on nine main topics—the role of cytoreductive surgery (CRS), patient selection for CRS, preoperative workup, role of systemic chemotherapy (SC), CPM with other visceral metastases, molecular profile, hyperthermic intraperitoneal chemotherapy (HIPEC) and other modalities of intraperitoneal chemotherapy (IPC), prophylactic/preventive strategies, and surveillances after CRS. A consensus was achieved if anyone option received >70 votes (strong consensus >90%). RESULTS: Forty-eight surgical (n = 41) and gastrointestinal (n = 7) oncologists were invited; 44 agreed to participate. The response rate was 95.4% (42/44) in round 1 and 93.1% (41/44) in round 2. Overall, a consensus was achieved on 23/29 (79.3%) questions (strong consensus on 6/29 [20.6%]). The panel strongly recommended considering surgery for limited CPM with limited liver metastases (92.5%), not altering the surgical approach in patients with KRAS mutations (91.67%), and limiting the use of IPC for unresectable CPM outside clinical trials (95%). Adjuvant SC was recommended for all patients undergoing CRS (89.47%). CRS is a therapeutic option for selected patients with CPM including those with metachronous CPM (79.49) and signet ring cell cancers (76.92%). HIPEC was recommended outside clinical trials only for patients with peritoneal cancer index 11-15(80%). CONCLUSION: The panel recommended CRS for most indications but was very selective in recommending HIPEC and IPC outside clinical trials. These recommendations should be a useful resource in clinical decision making for clinicians treating CPM in India and regions with a similar sociodemographic background.
- 9 September 2024
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 15 (S4) , 616-621
Adamantinoma-Like Ewing Sarcoma Arising in the Neck of Pancreas: A Rare Case Report with Literature Review
Adamantinoma-like Ewing's sarcoma (ALES) is a rare variant of Ewing sarcoma that is defined by complex epithelial differentiation, including expression of cytokeratin and p40 and frequent keratin pearl formation, having characteristic EWSR1-FLI1 translocation, typically observed in the head and neck region of middle-aged individuals. We present the first reported case of a 22-year-old female with ALES arising in the pancreatic neck, sharing similarities with its head and neck counterpart in the form of morphological, immunohistochemical, and high grade histological features. The case highlights diagnostic challenges and expands the understanding of ALES in uncommon anatomical locations.
- 9 September 2024
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 15 (S4) , 616-621
Adamantinoma-Like Ewing Sarcoma Arising in the Neck of Pancreas: A Rare Case Report with Literature Review
Adamantinoma-like Ewing's sarcoma (ALES) is a rare variant of Ewing sarcoma that is defined by complex epithelial differentiation, including expression of cytokeratin and p40 and frequent keratin pearl formation, having characteristic EWSR1-FLI1 translocation, typically observed in the head and neck region of middle-aged individuals. We present the first reported case of a 22-year-old female with ALES arising in the pancreatic neck, sharing similarities with its head and neck counterpart in the form of morphological, immunohistochemical, and high grade histological features. The case highlights diagnostic challenges and expands the understanding of ALES in uncommon anatomical locations.
- 20 August 2024
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 67 (11) , e1667
Laparoscopic Abdominoperineal Excision With En Bloc Prostatectomy for Locally Advanced Rectal Cancer
An abstract is unavailable. This article is available as a PDF only.
- 20 August 2024
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 67 (11) , e1667
Laparoscopic Abdominoperineal Excision With En Bloc Prostatectomy for Locally Advanced Rectal Cancer
An abstract is unavailable. This article is available as a PDF only.
- 8 August 2024
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 50 (10) , 108593
Two-stage cytoreductive surgery for ‘extensive’ pseudomyxoma peritonei: A legitimate alternative or salvage strategy?
- 8 August 2024
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 50 (10) , 108593
Two-stage cytoreductive surgery for ‘extensive’ pseudomyxoma peritonei: A legitimate alternative or salvage strategy?
- 16 June 2024
- Published by Wiley in Colorectal Disease
- Vol. 26 (8) , 1645-1646
Extended intersphincteric resection for low rectal cancer—A video vignette
- 16 June 2024
- Published by Wiley in Colorectal Disease
- Vol. 26 (8) , 1645-1646
Extended intersphincteric resection for low rectal cancer—A video vignette
- Open Access
- 31 December 2023
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 39 (6) , 474-483
Impact of consolidation chemotherapy in poor responders to neoadjuvant radiation therapy: magnetic resonance imaging–based clinical-radiological correlation in high-risk rectal cancers
Purpose: The current study was conducted to examine the role of consolidation chemotherapy after neoadjuvant radiation therapy (NART) in decreasing the involvement of the mesorectal fascia (MRF) in high-risk locally advanced rectal cancers (LARCs).Methods: In total, 46 patients who received consolidation chemotherapy after NART due to persistent MRF involvement were identified from a database. A team of 2 radiologists, blinded to the clinical data, studied sequential magnetic resonance imaging (MRI) scans to assess the tumor response and then predict a surgical plan. This prediction was then correlated with the actual procedure conducted as well as histopathological details to assess the impact of consolidation chemotherapy.Results: The comparison of MRI-based parameters of sequential images showed significant downstaging of T2 signal intensity, tumor height, MRF involvement, diffusion restriction, and N category between sequential MRIs (P < 0.05). However, clinically relevant downstaging (standardized mean difference, > 0.3) was observed for only T2 signal intensity and diffusion restriction on diffusion-weighted imaging. No clinically relevant changes occurred in the remaining parameters; thus, no change was noted in the extent of surgery predicted by MRI. Weak agreement (Cohen κ coefficient, 0.375) and correlation (Spearman rank coefficient, 0.231) were found between MRI-predicted surgery and the actual procedure performed. The comparison of MRI-based and pathological tumor response grading also showed a poor correlation.Conclusion: Evidence is lacking regarding the use of consolidation chemotherapy in reducing MRF involvement in LARCs. The benefit of additional chemotherapy after NART in decreasing the extent of planned surgery by reducing margin involvement requires prospective research.
- 31 December 2023
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 39 (6) , 474-483
Open AccessImpact of consolidation chemotherapy in poor responders to neoadjuvant radiation therapy: magnetic resonance imaging–based clinical-radiological correlation in high-risk rectal cancers
Purpose: The current study was conducted to examine the role of consolidation chemotherapy after neoadjuvant radiation therapy (NART) in decreasing the involvement of the mesorectal fascia (MRF) in high-risk locally advanced rectal cancers (LARCs).Methods: In total, 46 patients who received consolidation chemotherapy after NART due to persistent MRF involvement were identified from a database. A team of 2 radiologists, blinded to the clinical data, studied sequential magnetic resonance imaging (MRI) scans to assess the tumor response and then predict a surgical plan. This prediction was then correlated with the actual procedure conducted as well as histopathological details to assess the impact of consolidation chemotherapy.Results: The comparison of MRI-based parameters of sequential images showed significant downstaging of T2 signal intensity, tumor height, MRF involvement, diffusion restriction, and N category between sequential MRIs (P < 0.05). However, clinically relevant downstaging (standardized mean difference, > 0.3) was observed for only T2 signal intensity and diffusion restriction on diffusion-weighted imaging. No clinically relevant changes occurred in the remaining parameters; thus, no change was noted in the extent of surgery predicted by MRI. Weak agreement (Cohen κ coefficient, 0.375) and correlation (Spearman rank coefficient, 0.231) were found between MRI-predicted surgery and the actual procedure performed. The comparison of MRI-based and pathological tumor response grading also showed a poor correlation.Conclusion: Evidence is lacking regarding the use of consolidation chemotherapy in reducing MRF involvement in LARCs. The benefit of additional chemotherapy after NART in decreasing the extent of planned surgery by reducing margin involvement requires prospective research.